RARE · Ultragenyx Pharmaceutical Inc
United States · RS rating 29 · As of 2026-11-03
| Price | 16.63 USD |
|---|---|
| 1-day change | +2.0% |
| RS rating (overall / 1M / 3M / 12M) | 29 / 89 / 18 / 21 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 34 / 10 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +28.7% |
| Sales growth Q/Q | +29.6% |
| Distance from 52-week high | +54.5% |
| Market cap (USD) | $2.4B |